|
 Viewing Author

Entries for 'jon'

In December 2011, Tekturna® manufacturer Novartis announced its decision to terminate the clinical ALTITUDE study of the blood pressure drug based on the recommendation of the independent Data Monitoring Committee (DMC) overseeing the clinical trial study. 

 Following a November 2011 warning issued by the European Medicines Agency (EMA), the Food and Drug Administration (FDA) decided to reevaluate the safety of Pradaxa®. 

Support The North American Declaration to Ban Asbestos - Sign The Petition

 The Asbestos Disease Awareness Organization (ADAO) which combines education, advocacy, and community to provide a unified voice for asbestos victims, today announced with the Canadian Voices of Asbestos Victims the release of the North American Declaration to Eliminate Asbestos-Related Diseases.

New Facebook Address for Injured Workers Law and Advocacy Group

Facebook has changed its group services and the Injured Workers Law and Advocacy Group is moving forward with them. 

A NJ Court of Appeals has affirmed a decision awarding total disability workers' compensation benefits to an injured worker who suffers from bilateral carpal tunnel injuries.

Privacy, Clients and Social Media Discussion

Jon Gelman discuss privacy and their clients, client responsibility when it comes to putting up information on social media sites and how social networking can be used as a portal to monitor clients.

  A Delaware Bankruptcy Judge has approved a reorganization plan  for the former asbestos manufacturer, WR Grace.

The Triangle Fire Airs on PBS Feb 28, 2011

 It was the deadliest workplace accident in New York City’s history.

Facebook Becomes a Questionable Friend of Workers Compensation

 Social networking’s popularity has become a two-edged sword as a tool in the management, investigation, and disposition of workers’ compensation claims. 

  Cooper Industries has reportedly settled an indemnification  lawsuit. and agreed to pay Pneumo Abex asbestos trust $307.5 Million. The trust funds will be used to pay victims of asbestos exposure.

Lawsuit Filed By Former Hoffman LaRoche Employee Alleging Asbestos Related Disease

A lawsuit was filed alleging that a former pharmaceutical maintenance specialist at Hoffman-LaRoche in Nutley, New Jersey was exposed to asbestos fiber and suffers from asbestosis. 

Auto Mechanic Files Lawsuit Alleging Asbestos Related Disease

A lawsuit was filed alleging that a former auto mechanic, who worked in auto body shops throughout New Jersey, was exposed to asbestos fiber and suffers from lung cancer.

 

Bar Date Announced for Raytech  Asbestos Claims

TheRaytech Trust, encompassing the claims of The Raybestos Manhattan and Raymark Industries, Inc.,  has established a bar date for asbestos liability claims.

Hot Topics in Workers’ Compensation Law 2011 Seminar

 This popular annual program, offered by the NJ Institute for Continuing Legal Education (NJICLE), is geared to both the novice and expert Workers’ Compensation attorney. It provides important and essential information to understand the cutting edge and critical issues confronting those who practice workplace injury law.

   The US House of Representative has passed a resolution designating September 26 as National Mesothelioma Awareness Day. The ac...
Veterans at Increased Risk for Mesothelioma

  The US Department of Veterans Affairs  has now recognized that veterans may be at an increased risk for the development of mesothelioma, a cancer associated with exposure to asbestos fiber.

FDA Votes to Restrict Avandia Due to Risks

Jon L Gelman is investigating cases involving individuals who have suffered a heart attack, ischemic stroke or other cardiac condition while taking Avandia for diabetes.

 A lawsuit was filed alleging that a former chemical operator at Hoffman-LaRoche in Nutley, New Jersey was exposed to asbestos fiber and died of mesothelioma. 

Allianz Firemans Fund Increases Asbestos Reserves by $301 Million

Fireman's Fund Insurance Company a Division of Allianz has announced that it will increase its asbestos and environmental risks reserve by $301 Million. The company stated, "The move follows the completion of its regular independent external asbestos exposure review."

Jon Gelman is investigating cases involving infant drugs manufactured by pharmaceutical company McNeil Consumer Healthcare including include certain liquid infant’s and children’s Tylenol®, Motrin®, Zyrtec®, and Benadryl® products.

Page 3 of 27First   Previous   1  2  [3]  4  5  6  7  8  9  10  Next   Last   
Copyright 2019 by Jon Gelman, LLC - Attorney at Law. All rights reserved.   |  Privacy Statement  |  Terms Of Use